(Q72529384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Effect of the new somatostatin analogue SMS 201-995 on exogenously used insulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

M Bayraktar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

A Usman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Z Koray

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 September 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

669-672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00212984

27 October 2019

exact match

0 references

cites work

Somatostatin impairs clearance of exogenous insulin in humans

1 reference

12 December 2020

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Exogenous somatostatin raises plasma insulin levels in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjects

1 reference

12 December 2020

Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

1 reference

12 December 2020

Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas

1 reference

12 December 2020

Pharmacokinetics of SMS 201-995 in healthy subjects

1 reference

12 December 2020

The renal metabolism of insulin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00212984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7849444%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference